These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 500143)

  • 1. On significance of plasma fibrinogen level to assess severity of myocardial damage--an experimental study.
    Saxena KK; Gupta B; Srivastava VK; Kulshrestha VK; Prasad DN
    Indian J Exp Biol; 1979 Jun; 17(6):600-2. PubMed ID: 500143
    [No Abstract]   [Full Text] [Related]  

  • 2. An experimental investigation to correlate changes in plasma fibrinolytic activity with isoprenaline induced myocardial damage.
    Saxena KK; Gupta B; Kulshrestha VK; Prasad DN
    J Postgrad Med; 1979 Jul; 25(3):147-53. PubMed ID: 529166
    [No Abstract]   [Full Text] [Related]  

  • 3. [Myocardial DNA and cell count following isoproterenol-induced myocardial necrosis in the rat].
    Adler CP
    Verh Dtsch Ges Pathol; 1975; 59():589. PubMed ID: 1217150
    [No Abstract]   [Full Text] [Related]  

  • 4. Isoproterenol-induced myocardial infarction in rabbits. Protection by propranolol or labetalol: a proposed non-invasive procedure.
    Pinelli A; Trivulzio S; Tomasoni L; Brenna S; Bonacina E; Accinni R
    Eur J Pharm Sci; 2004 Nov; 23(3):277-85. PubMed ID: 15489129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propranolol on plasma fibrinogen, fibrinolytic activity and cardiac injury following isoprenaline challenge in rats.
    Saxena KK; Gupta B; Srivastava RK; Prasad DN
    Indian Heart J; 1981; 33(3):91-4. PubMed ID: 7298064
    [No Abstract]   [Full Text] [Related]  

  • 6. Quantitation of isoproterenol-induced myocardial necrosis with 3H-tetracycline.
    Ryan CF; Athari-Nejad A; Holcslaw TL
    Res Commun Chem Pathol Pharmacol; 1979 Sep; 25(3):489-501. PubMed ID: 504787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxyfedrine and propranolol. A comparative experimental approach to protect myocardium against isoprenaline-induced myocardial necrosis.
    Seth SD; Gupta MP; Gupta M; Manchanda SC
    Arzneimittelforschung; 1984; 34(6):678-83. PubMed ID: 6541488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma fibrinogen and serum enzymes: relative significance as prognostic indicator in acute myocardial infarction.
    Saxena KK; Gupta B; Gopal R; Srivastava SS; Singh RC; Kulshrestha VK; Prasad DN
    J Assoc Physicians India; 1986 Sep; 34(9):641-2. PubMed ID: 3793700
    [No Abstract]   [Full Text] [Related]  

  • 9. [Vitamin E (tocopherol) levels in the blood serum and myocardium of rats with myocardial micronecrosis caused by stimulation with isoprenaline].
    Ostrowski J
    Pol Tyg Lek; 1980 Jan; 35(2):45-7. PubMed ID: 7367325
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic value of plasma fibrinogen in myocardial infarction.
    Gopal R; Saxena KK; Gupta B; Srivastava SS; Srivastava RK; Prasad DN
    J Postgrad Med; 1983 Oct; 29(4):233-5. PubMed ID: 6672181
    [No Abstract]   [Full Text] [Related]  

  • 11. Myocardial damage vis-a-vis plasma fibrinolytic activity and fibrinogen level--an experimental study.
    Saxena KK; Srivastava RK; Prasad DN
    Indian J Med Res; 1979 Aug; 70():263-7. PubMed ID: 521096
    [No Abstract]   [Full Text] [Related]  

  • 12. Isoproterenol myocytolysis and myocardial calcium.
    Bloom S; Davis D
    Recent Adv Stud Cardiac Struct Metab; 1974; 4():581-90. PubMed ID: 4468469
    [No Abstract]   [Full Text] [Related]  

  • 13. [Characteristics of the development of sympathomimetic heart lesions depending on the adaptation to intermittent exogenic hyperthermia].
    Sobolevskiĭ VI; Eliseev VV
    Vopr Kurortol Fizioter Lech Fiz Kult; 1984; (2):38-40. PubMed ID: 6730388
    [No Abstract]   [Full Text] [Related]  

  • 14. [Statistical and clinical study of the significance of fibrinogenemia in the course of myocardial infarct].
    Bosisio P; Lolli G
    Cardiol Prat; 1967 Feb; 18(1):9-19. PubMed ID: 5600978
    [No Abstract]   [Full Text] [Related]  

  • 15. [Modeling of myocardial lesions of varying degrees of manifestation].
    Reznikov KM; Leonov AN; Kitaeva RI; Bykov EG; Provotorova PP
    Biull Eksp Biol Med; 1985 May; 99(5):532-4. PubMed ID: 4005403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphophysiological studies in experimental myocardial aggressions with isoproterenol. Note I. Morphological aspects.
    Laky D; Constantinescu S; Filipescu G; Ratea E; Zeană C
    Morphol Embryol (Bucur); 1983; 29(4):273-7. PubMed ID: 6228730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Lipistat in protection against isoproterenol induced myocardial necrosis in rats: a biochemical and histopathological study.
    Seth SD; Maulik M; Katiyar CK; Maulik SK
    Indian J Physiol Pharmacol; 1998 Jan; 42(1):101-6. PubMed ID: 9513800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of free fatty acids in catecholamine-induced cardiac necrosis.
    Kjekshus JK
    Recent Adv Stud Cardiac Struct Metab; 1975; 6():183-91. PubMed ID: 1197880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of leukopenia on myocardial necrosis induced by isoproterenol].
    Segal A; Laguens RP
    Medicina (B Aires); 1978; 38(5):537-40. PubMed ID: 739888
    [No Abstract]   [Full Text] [Related]  

  • 20. Subcutaneous isoproterenol: a convenient rat model for early detection of myocardial necrosis.
    Kung HF; Blau M
    J Nucl Med; 1978 Aug; 19(8):948-51. PubMed ID: 682027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.